Long Term Safety and Tolerability of Satavaptan in Patients with Cirrhosis of the Liver That Have Been Previously Randomized and Completed Treatment in Any of the Phase III Studies: EFC4492, EFC4493 or EFC6682:

  • Koch, Alvaro (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/7/089/30/08